Form 4: MercadoLibre Director Sells Shares in Recent Transaction
SEC Form 4 Filing
Director Emiliano Calemzuk sold 50 shares of MercadoLibre stock at $1,984.98 per share on November 29, 2024.
Summary
- Emiliano Calemzuk, a director at MercadoLibre Inc., sold 50 shares of common stock on November 29, 2024.
- The sale price was $1,984.98 per share.
- Following the transaction, Mr. Calemzuk directly owns 238 shares and indirectly owns 170 shares through a retirement account.
- The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of a stock sale by a director, which is neither positive nor negative in itself. It is a neutral event.
Industry Context
This is a routine disclosure of a stock sale by a company director, which is common practice for publicly traded companies. It does not indicate any specific trend in the e-commerce industry.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, such as Amazon (AMZN) and eBay (EBAY), when insiders trade company stock.
- The reporting requirements are consistent across all companies listed on US exchanges.
Stakeholder Impact
- The stock sale by a director may have a minor impact on shareholder sentiment, but it is unlikely to significantly affect the company's operations or financial performance.
Key Dates
| Date | Description |
|---|---|
| 11/29/2024 | Date of the stock sale transaction. |
| 12/02/2024 | Date the Form 4 was signed. |
Keywords
MercadoLibre, MELI, stock sale, insider trading, Form 4, director, Emiliano Calemzuk
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.